Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jun;2(2):140-53.
doi: 10.1007/s11481-007-9070-6. Epub 2007 Mar 31.

Divergent roles for tumor necrosis factor-alpha in the brain

Affiliations
Review

Divergent roles for tumor necrosis factor-alpha in the brain

Krishnan Sriram et al. J Neuroimmune Pharmacol. 2007 Jun.

Abstract

Proinflammatory cytokines and chemokines have been implicated in the pathogenesis of several neurological and neurodegenerative disorders. Prominent among such factors is the pleiotropic cytokine, tumor necrosis factor (TNF)-alpha. Under normal physiological conditions, TNF-alpha orchestrates a diverse array of functions involved in immune surveillance and defense, cellular homeostasis, and protection against certain neurological insults. However, paradoxical effects of this cytokine have been observed. TNF-alpha is elicited in the brain following injury (ischemia, trauma), infection (HIV, meningitis), neurodegeneration (Alzheimer's, Parkinson's), and chemically induced neurotoxicity. The multifarious identity for this cytokine appears to be influenced by several mechanisms. Among the most prominent are the regulation of TNFalpha-induced NF-kappaB activation by adapter proteins such as TRADD and TRAF, and second, the heterogeneity of microglia and their distribution pattern across brain regions. Here, we review the differential role of TNF-alpha in response to brain injury, with emphasis on neurodegeneration, and discuss the possible mechanisms for such diverse and region-specific effects.

PubMed Disclaimer

References

    1. J Neuroimmunol. 1996 May;66(1-2):115-23 - PubMed
    1. J Neurovirol. 2002 Apr;8(2):69-75 - PubMed
    1. Mol Med. 1997 Nov;3(11):765-81 - PubMed
    1. J Mol Neurosci. 2006;29(3):279-88 - PubMed
    1. J Pharmacol Exp Ther. 2004 Oct;311(1):1-7 - PubMed

MeSH terms

Substances

LinkOut - more resources